Modulation of myocardial stiffness by β-adrenergic stimulation - Its role in normal and failing heart

Physiological Research

Volumn 60, Issue 4, 2011, Pages 599-609

  Falcao Pires I ^a   Fontes Sousa, A P ^a,b   Lopes Conceicao L ^a   Bras Silva C ^a,b   Leite Moreira, A F ^a  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

Diastolic function; Heart failure; Myocardial stiffness; adrenergic stimulation

Indexed keywords

EID: 80053633681     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: 10.33549/physiolres.932088     Document Type: Article

References (57)

1. ARNOLDA L, McGRATH B, COCKS M, SUMITHRAN E, JOHNSTON C: Adriamycin cardiomyopathy in the rabbit: an animal model of low output cardiac failure with activation of vasoconstrictor mechanisms. Cardiovasc Res 19: 378-382,1985.
2. BERS DM: Cardiac excitation-contraction coupling. Nature 415: 198-205,2002.
3. BERS DM, GUO T: Calcium signaling in cardiac ventricular myocytes. Ann N Y Acad Sci 1047: 86-98,2005.
4. BISHOPRIC NH, SATO B, WEBSTER KA: Beta-adrenergic regulation of a myocardial actin gene via a cyclic AMPindependent pathway. J Biol Chem 267: 20932-20936,1992.
5. BORBELY A, FALCAO-PIRES I, VAN HEEREBEEK L, HAMDANI N, EDES I, GAVINA C, LEITE-MOREIRA AF, BRONZWAER JG, PAPP Z, VAN DER VELDEN J, STIENEN GJ, PAULUS WJ: Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 104: 780-786,2009.
6. BORBELY A, VAN DER VELDEN J, PAPP Z, BRONZWAER JG, EDES I, STIENEN GJ, PAULUS WJ: Cardiomyocyte stiffness in diastolic heart failure. Circulation 111: 774-781,2005.
7. BRAS-SILVA C, FONTES-SOUSA AP, MOURA C, AREIAS JC, LEITE-MOREIRA AF: Impaired response to ET(B) receptor stimulation in heart failure: functional evidence of endocardial endothelial dysfunction? Exp Biol Med (Maywood) 231: 893-898,2006.
8. BRAS-SILVA C, LEITE-MOREIRA AF: Obligatory role of the endocardial endothelium in the increase of myocardial distensibility induced by endothelin-1. Exp Biol Med (Maywood) 231: 876-881,2006.
9. BRAS-SILVA C, MONTEIRO-SOUSA D, DUARTE AJ, GUERRA M, FONTES-SOUSA AP, MOURA C, AREIAS JC, LEITE-MOREIRA AF: Nitric oxide and prostaglandins - important players in endothelin-1 induced myocardial distensibility. Physiol Res 57: 165-174,2008.
10. BRISTOW MR, GINSBURG R, UMANS V, FOWLER M, MINOBE W, RASMUSSEN R, ZERA P, MENLOVE R, SHAH P, JAMIESON S, STINSON EB: Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 59: 297-309, 1986.
11. BRODDE OE, BRUCK H, LEINEWEBER K: Cardiac adrenoceptors: physiological and pathophysiological relevance. J Pharmacol Sci 100: 323-337,2006.
12. BRONZWAER JG, PAULUS WJ: Matrix, cytoskeleton, or myofilaments: which one to blame for diastolic left ventricular dysfunction? Prog Cardiovasc Dis 47: 276-284,2005.
13. BRUTSAERT DL, CLAES VA, SONNENBLICK EH: Velocity of shortening of unloaded heart muscle and the lengthtension relation. Circ Res 29: 63-75,1971.
14. BRUTSAERT DL, MEULEMANS AL, SIPIDO KR, SYS SU: Effects of damaging the endocardial surface on the mechanical performance of isolated cardiac muscle. Circ Res 62: 358-366,1988.
15. CURRAN J, HINTON MJ, RIOS E, BERS DM, SHANNON TR: Beta-adrenergic enhancement of sarcoplasmic reticulum calcium leak in cardiac myocytes is mediated by calcium/calmodulin-dependent protein kinase. Circ Res 100: 391-398,2007.
16. 2-adrenoceptor agonists in guinea pig right papillary muscles. Am J Physiol Cell Physiol 294: C106-C117,2008.
17. FENTZKE RC, BUCK SH, PATEL JR, LIN H, WOLSKA BM, STOJANOVIC MO, MARTIN AF, SOLARO RJ, MOSS RL, LEIDEN JM: Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J Physiol Lond 517: 143-157,1999.
18. FONTES-SOUSA AP, BRAS-SILVA C, PIRES AL, MONTEIRO-SOUSA D, LEITE-MOREIRA AF: Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling. Naunyn Schmiedebergs Arch Pharmacol 376: 107-115,2007.
19. FONTES-SOUSA AP, PIRES AL, CARNEIRO CS, BRAS-SILVA C, LEITE-MOREIRA AF: Effects of adrenomedullin on systolic and diastolic myocardial function. Peptides 30: 796-802,2009.
20. FUKUDA N, WU Y, NAIR P, GRANZIER HL: Phosphorylation of titin modulates passive stiffness of cardiac muscle in a titin isoform-dependent manner. J Gen Physiol 125: 257-271,2005.
21. GOTOH H: Phosphorylation and adrenergic chronotropism and inotropism in guinea pig cardiac muscles. Life Sci 56: 1655-1663, 1995.
22. GRUEN M, PRINZ H, GAUTEL M: cAPK-phosphorylation controls the interaction of the regulatory domain of cardiac myosin binding protein C with myosin-S2 in an on-off fashion. FEBS Lett 453: 254-259,1999.
23. HAIKALA H, KAHEINEN P, LEVIJOKI J, LINDEN IB: The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res 34: 536-546,1997.
24. HIDALGO C, HUDSON B, BOGOMOLOVAS J, ZHU Y, ANDERSON B, GREASER M, LABEIT S, GRANZIER H: PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res 105: 631-638,2009.
25. IWAI-KANAI E, HASEGAWA K, ARAKI M, KAKITA T, MORIMOTO T, SASAYAMA S: Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes. Circulation 100: 305-311,1999.
26. JOHNS EC, SIMNETT SJ, MULLIGAN IP, ASHLEY CC: Troponin I phosphorylation does not increase the rate of relaxation following laser flash photolysis of diazo-2 in guinea-pig skinned trabeculae. Pflugers Arch 433: 842-844,1997.
27. KASS DA, BRONZWAER JG, PAULUS WJ: What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94:1533-1542,2004.
28. KIEHN J, KARLE C, THOMAS D, YAO X, BRACHMANN J, KUBLER W: HERG potassium channel activation is shifted by phorbol esters via protein kinase A-dependent pathways. J Biol Chem 273: 25285-25291,1998.
29. KIZAKI K, AKATSUKA K, MOMOZAKI M, FUJIMORI Y, UCHIDE T, TEMMA K, HARA Y: Changes in myocardial beta 1-adrenergic receptor and stimulatory G-protein gene expression after chronic treatment with doxorubicin in rat. J Vet Med Sci 66: 989-992,2004.
30. KRUGER M, KOTTER S, GRUTZNER A, LANG P, ANDRESEN C, REDFIELD MM, BUTT E, DOS REMEDIOS CG, LINKE WA: Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 104: 87-94,2009.
31. KRUGER M, LINKE WA: Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol 46: 490-498,2009.
32. KUNST G, KRESS KR, GRUEN M, UTTENWEILER D, GAUTEL M, FINK RH: Myosin binding protein C, a phosphorylation-dependent force regulator in muscle that controls the attachment of myosin heads by its interaction with myosin S2. Circ Res 86: 51-58,2000.
33. LEITE-MOREIRA AF: Current perspectives in diastolic dysfunction and diastolic heart failure. Heart 92: 712-718,2006.
34. 8 receptor stimulation and their modulation by endocardial endothelium, NO, and prostaglandins. Am J Physiol Heart Circ Physiol 287: H1194-H1199,2004.
35. + exchanger-mediated effect. Am J Physiol Heart Circ Physiol 284: H1332-H1339,2003.
36. + exchanger-mediated effect. Br J Pharmacol 147: 690-697,2006.
37. LEITE-MOREIRA AF, CORREIA-PINTO J, HENRIQUES-COELHO T: Interaction between load and beta-adrenergic stimulation in the modulation of diastolic function (in Portugese). Rev Port Cardiol 20: 57-62,2001.
38. MARIAN AJ: Beta-adrenergic receptors signaling and heart failure in mice, rabbits and humans. J Mol Cell Cardiol 41: 11-13,2006.
39. MAURICE JP, SHAH AS, KYPSON AP, HATA JA, WHITE DC, GLOWER DD, KOCH WJ: Molecular beta-adrenergic signaling abnormalities in failing rabbit hearts after infarction. Am J Physiol 276: H1853-H1860,1999.
40. MOHAN P, BRUTSAERT DL, SYS SU: Myocardial performance is modulated by interaction of cardiac endothelium derived nitric oxide and prostaglandins. Cardiovasc Res 29: 637-640, 1995.
41. NAGAMI K, YOSHIKAWA T, SUZUKI M, WAINAI Y, ANZAI T, HANDA S: Abnormal beta-adrenergic transmembrane signaling in rabbits with adriamycin-induced cardiomyopathy. Jpn Circ J 61: 249-255,1997.
42. NAGUEH SF, SHAH G, WU Y, TORRE-AMIONE G, KING NM, LAHMERS S, WITT CC, BECKER K, LABEIT S, GRANZIER HL: Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 110: 155-162, 2004.
43. PAULUS WJ, VANTRIMPONT PJ, SHAH AM: Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion. Circulation 89: 2070-2078, 1994.
44. 2+-regulatory site of bovine cardiac troponin. J Biol Chem 257: 260-263, 1982.
45. SHAH AM, MACCARTH Y PA: Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol Ther 86: 49-86,2000.
46. SINGH K, XIAO L, REMONDINO A, SAWYER DB, COLUCCI WS: Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189: 257-265,2001.
47. STEINBERG SF: The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes. Circ Res 85: 1101-1111,1999.
48. VAN HEEREBEEK L, BORBELY A, NIESSEN HW, BRONZWAER JG, VAN DER VELDEN J, STIENEN GJ, LINKE WA, LAARMAN GJ, PAULUS WJ: Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113: 1966-1973,2006.
49. VARMA DR, SHEN H, DENG XF, PERI KG, CHEMTOB S, MULAY S: Inverse agonist activities of beta-adrenoceptor antagonists in rat myocardium. Br J Pharmacol 127: 895-902, 1999.
50. 2+/calmodulin kinase signaling pathway. Circ Res 95: 798-806,2004.
51. WATTANAPERMPOOL J, GUO X, SOLARO RJ: The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Mol Cell Cardiol 27: 1383-1391, 1995.
52. 2-adrenergic receptor to G(s) and G(i) proteins. Sci STKE 2001:rel5,2001.
53. 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes. Mol Pharmacol 47: 322-329,1995.
54. 2 receptor subtype and evidence for PKA-independent activation of the channel. Cell Signal 11: 337-342, 1999.
55. ZHANG R, ZHAO J, MANDVENO A, POTTER JD: Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 76: 1028-1035, 1995.
56. 2+/calmodulin kinase II. J Clin Invest 111: 617-625,2003.
57. ZIMMERMANN WH, SCHNEIDERBANGER K, SCHUBERT P, DIDIE M, MUNZEL F, HEUBACH JF, KOSTIN S, NEUHUBER WL, ESCHENHAGEN T: Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223-230,2002.